Within just a few years, after the foundation in 2002, AxiCorp has grown into an international group with more than 250 employees.

It now achieves cost savings amounting to millions for the German healthcare sector, and manufactures and distributes several hundred different EU pharmaceuticals as well as its own generics brand axcount.

Not only does AxiCorp consistently bring about cost savings for the healthcare sector and generate jobs in its region, it has also proved itself to be a reliable, innovative service partner and pharmacy market expert servicing pharmacies and pharmaceutical wholesalers in Germany.

Strategic partnership taps innovative business area
In February 2008 AxiCorp and Biocon, one of the world's leading biotechnology groups, came together sharing a vision of affordable healthcare on the highest scientific level. This strategic partnership pools the know-how, unique in the world, of Biocon in the field of research, development and production of biotechnological medicines with the marketing, distribution and logistics expertise of AxiCorp on the European health market. The goals and ambitions of the group of companies is to rank amongst the leading providers in all three business areas – EU pharmaceuticals, Generics and Biosimilars – within five years.